
    
      Observing the efficacy and safety of apatinib in heavily treated non-squamous non-small cell
      lung cancer.

      Primary Outcome Measure: Objective Response Rate Secondary Outcome Measures: Progression free
      survival, overall survival, Side effects, Quality Of Life
    
  